A randomized controlled study of the efficacy of an intensified, partial inpatient adaptation of Dialectical Behavior Therapy (DBT) for a population of Borderline patients (young adults/adults:18 - 40), compared with standard outpatient DBT

*A randomized controlled study of the efficacy of an intensified, partial inpatient adaptation of Dialectical Behavior Therapy (DBT) for a population of Borderline patients (young adults/adults:18 - 40), compared with standard outpatient DBT* - Inpatient intensified adaptation of DBT vs standard outpatient DBT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35751

Enrollment

Registered

2011-08-15

Start date

2012-02-20

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe emotional disturbance severe personality disorder suicidal/ selfdestructive behavior

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (young) adult borderline patients with severe suicidal and selfdestructive behavior with al least 6 out of 9 diagnostic criteria of the DSM-IV TR of the bordeline personality disorder, with a Borderline Personality Disorder Severity Index total score of at least 24.

Exclusion criteria

Exclusion criteria: IQ

Design outcomes

Primary

Measure	Time frame
Main study parameter is the number of suicide attempts/self-destructive acts (measured by the Life Time Parasuicide Count and The Borderline Personality Severity Index). We expect that after 12 weeks 20% of the patients of the intervention group still show suicidal and/or self-destructive behaviour compared to 60% of the patients in the control condition, and that this difference sustains at 24 weeks and will gradually be reduced between 24 and 52 weeks.	—

Measure

Time frame

Main study parameter is the number of suicide attempts/self-destructive acts (measured by the Life Time Parasuicide Count and The Borderline Personality Severity Index). We expect that after 12 weeks 20% of the patients of the intervention group still show suicidal and/or self-destructive behaviour compared to 60% of the patients in the control condition, and that this difference sustains at 24 weeks and will gradually be reduced between 24 and 52 weeks.

—

Secondary

Measure	Time frame
Second study parameter is the severity of borderline symptomatology (as measured by the BPDSI), reduced BPDSI scores. The results on the SF-36 (Quality of life), on the BSI (psychopathological symptoms) and on the IDS-SR (depression), part of the Routine Outcome Monitoring of Rivierduinen, will be taken into account also. We expect a stronger decline in LPC scores and in BPDSI general symptomatology scores in the first 4 months, and that these differences sustain at 24 weeks and will gradually be reduced between 24 and 52 weeks.	—

Measure

Time frame

Second study parameter is the severity of borderline symptomatology (as measured by the BPDSI), reduced BPDSI scores. The results on the SF-36 (Quality of life), on the BSI (psychopathological symptoms) and on the IDS-SR (depression), part of the Routine Outcome Monitoring of Rivierduinen, will be taken into account also. We expect a stronger decline in LPC scores and in BPDSI general symptomatology scores in the first 4 months, and that these differences sustain at 24 weeks and will gradually be reduced between 24 and 52 weeks.

—

Countries

Netherlands

Outcome results